![2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-](https://static.cymitquimica.com/products/AN/img/AG000MK4.png "Cliccare per ingrandire")
2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-
CAS: 1246560-33-7
Rif. AN-AG000MK4
| 5mg | Fuori produzione | ||
| 10mg | Fuori produzione | ||
| 25mg | Fuori produzione | ||
| 50mg | Fuori produzione |
Informazioni sul prodotto
Nome:
2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-
Sinonimi:
- [u'5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine', u'SB2343', u'VS-5584', u'VS-5584', u'1246560-33-7', u'5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine', u'VS-5584 (SB2343)', u'SB2343', u'UNII-W71J4X250V', u'SB-2343', u'CHEMBL3393066', u'W71J4X250V', u'5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine', u'C17H22N8O', u'QYBGBLQCOOISAR-UHFFFAOYSA-N', u'5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine', u'SCHEMBL539098', u'GTPL8382', u'vs-5584-sb2343', u'DTXSID10677328', u'EX-A288', u'HMS3652B16', u'BCP08247', u'2797AH', u'BDBM50059635', u'MFCD25372027', u's7016', u'VS5584', u'ZINC95644685', u'AKOS024465057', u'CS-1202', u'DB12986', u'SB 2343', u'SB16877', u'NCGC00386370-03', u'NCGC00386370-06', u'AK163764', u'BC600432', u'DA-46738', u'DA-46740', u'HY-16585', u'AB0165544', u'AX8294897', u'FT-0700143', u'SW220201-1', u'A12480', u'W-6043', u'J-690096', u'5-[9-Isopropyl-8-methyl-2-(morpholin-4-yl)purin-6-yl]pyrimidin-2-amine', u'5-[8-Methyl-2-(morpholin-4-yl)-9-(propan-2-yl)-9H-purin-6-yl]pyrimidin-2-amine', u'SB-2343|||5-(8-Methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine', u'D01EUD', u'D0U3DP', u'ACN-029553', u'SB-2312', u'MPI-0479605', u'A3927', u'C585120', u'MTOR/PI3K alpha dual inhibitors (cancer), S*BIO', u'(S)-(+)-tert-Butyl 2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate', u'1246529-32-7', u'Mammalian target of rapamycin/phosphoinositide 3 kinase alpha dual inhibitors (cancer), S*Bio']
CAS:
Marchio:
Indagoo
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
354.4096
Formula:
C17H22N8O
Purezza:
98%
Colore/Forma:
Solid
InChI:
InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)
InChI key:
QYBGBLQCOOISAR-UHFFFAOYSA-N
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
